Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

The SGLT2 inhibitor, already approved for some high-risk heart failure patients, has now received a much wider approval. 

Myocarditis as seen on cardiac MRI in patients who recently received COVID-19 messenger RNA vaccination from a November 2021 imaging study. Image courtesy of the American Journal of Roentgenology (AJR)

New CDC guidance: Waiting longer between COVID-19 vaccine doses could reduce risk of heart damage

Waiting a few additional weeks, the agency wrote, could help limit myocarditis or pericarditis among young adults.

Recurrent MR after TEER: Tracking data from nearly 700 MitraClip patients

The new analysis focused on both primary and secondary MR 12 months after TEER. 

Thumbnail

Cardiologists identify 162 genes responsible for coronary heart disease

The team's findings, one researcher said, "could eventually make a huge impact on many patients lives."

A team of researchers at Gladstone, including Bárbara González Terán shown here seated, developed a novel algorithm method for identifying genetic variants that are likely to play important roles in congenital heart disease. This opens up opportunities to accelerate research into this serious condition. Photo by Michael Short/Gladstone Institutes

Algorithm helps sort genetic data to improve our understanding of congenital heart disease

Researchers at Gladstone Institutes developed a new algorithm method for identifying genetic variant combinations that are likely to play important roles in congenital heart disease.

Thumbnail

A potential new treatment for COVID-19 patients with MIS-C

The medication, originally developed to treat celiac disease, could provide significant relief for young MIS-C patients. 

Thumbnail

Amyloidosis patients can safely undergo TAVR

Researchers focused on 30-day outcomes, sharing their findings in the American Journal of Cardiology.

Thumbnail

Eating vegetables does little to prevent cardiovascular disease

Don't give up on eating vegetables quite yet—but a new analysis in Frontiers in Nutrition does suggest they can't protect you from CVD all on their own. 

Displaying 1841 - 1848 of 10748

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.